 CAMBRIDGE, Mass., Nov. 23, 2020 GLOBE NEWSWIRE -- Constellation Pharmaceuticals , Inc. Nasdaq: CNST, a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, will host a virtual analystinvestor event and conference call on December 7 at 8:00 AM EDT to discuss the data from two oral presentations and two posters on the MANIFEST clinical trial for CPI-0610 being presented at the 62nd American Society of Hematology ASH Annual Meeting and Exposition. 